Jounce Therapeutics, Inc. (9)
Browse by Contract Category
Contracts
-
Underwriting Agreement, dated March 9, 2021, by and among Jounce Therapeutics, Inc., Cowen and Company, LLC and Piper Sandler & Co., as representatives of the several underwriters...
(Filed With SEC on March 10, 2021)
-
Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on February 25, 2021)
-
License Agreement by and between the Registrant and Gilead Sciences, Inc., dated as of August 31, 2020
(Filed With SEC on November 6, 2020)
-
Description of Securities
(Filed With SEC on February 27, 2020)
-
Sales Agreement, dated as of December 17, 2019, by and between the Company and Cowen and Company, LLC
(Filed With SEC on December 17, 2019)
-
Stock Purchase Agreement by and between the Registrant and Gilead Sciences, Inc. dated as of August 31, 2020
(Filed With SEC on November 6, 2020)
-
Registration Rights Agreement by and between the Registrant and Gilead Sciences, Inc., dated as of August 31, 2020
(Filed With SEC on November 6, 2020)
-
License Agreement by and among the Registrant, Celgene Corporation, and Celgene RIVOT LLC, dated July 22, 2019
(Filed With SEC on November 7, 2019)
-
Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on May 8, 2019)